19647866

Source:http://linkedlifedata.com/resource/pubmed/id/19647866

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0009429, umls-concept:C0019704, umls-concept:C0021311, umls-concept:C0030705, umls-concept:C0036043, umls-concept:C0556895, umls-concept:C2587213
pubmed:issue	9692
pubmed:dateCreated	2009-9-7
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00369941
pubmed:abstractText	Use of raltegravir with optimum background therapy is effective and well tolerated in treatment-experienced patients with multidrug-resistant HIV-1 infection. We compared the safety and efficacy of raltegravir with efavirenz as part of combination antiretroviral therapy for treatment-naive patients.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19647866, http://linkedlifedata.com/resource/pubmed/commentcorrection/19647866-19647865
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzoxazines, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/MK 0518, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Pyrrolidinones, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/efavirenz, http://linkedlifedata.com/resource/pubmed/chemical/emtricitabine, http://linkedlifedata.com/resource/pubmed/chemical/tenofovir
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1474-547X
pubmed:author	pubmed-author:BarnardRichard J ORJ, pubmed-author:BergerDaniel SDS, pubmed-author:DeJesusEdwinE, pubmed-author:DiNubileMark JMJ, pubmed-author:LazzarinAdrianoA, pubmed-author:LeavittRandiR, pubmed-author:LennoxJeffrey LJL, pubmed-author:MadrugaJose Valdez RamalhoJV, pubmed-author:MillerMichael DMD, pubmed-author:NguyenBach-YenBY, pubmed-author:PollardRichard BRB, pubmed-author:RodgersAnthony JAJ, pubmed-author:STARTMRK investigators, pubmed-author:SklarPeterP, pubmed-author:TangRosaR, pubmed-author:Williams-DiazAngelaA, pubmed-author:ZhaoJingJ
pubmed:issnType	Electronic
pubmed:day	5
pubmed:volume	374
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	796-806
pubmed:dateRevised	2009-12-28
pubmed:meshHeading	pubmed-meshheading:19647866-Adenine, pubmed-meshheading:19647866-Adult, pubmed-meshheading:19647866-Analysis of Variance, pubmed-meshheading:19647866-Anti-HIV Agents, pubmed-meshheading:19647866-Benzoxazines, pubmed-meshheading:19647866-Deoxycytidine, pubmed-meshheading:19647866-Double-Blind Method, pubmed-meshheading:19647866-Drug Therapy, Combination, pubmed-meshheading:19647866-Female, pubmed-meshheading:19647866-HIV Infections, pubmed-meshheading:19647866-HIV-1, pubmed-meshheading:19647866-Humans, pubmed-meshheading:19647866-Male, pubmed-meshheading:19647866-Phosphonic Acids, pubmed-meshheading:19647866-Prognosis, pubmed-meshheading:19647866-Pyrrolidinones, pubmed-meshheading:19647866-RNA, Viral, pubmed-meshheading:19647866-Safety, pubmed-meshheading:19647866-Treatment Outcome, pubmed-meshheading:19647866-Viral Load
pubmed:year	2009
pubmed:articleTitle	Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
pubmed:affiliation	Emory University School of Medicine, Atlanta, GA, USA.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III